Holmes Biopharma, Inc.
OTC Bulletin Board : HLMB

Holmes Biopharma, Inc.

August 24, 2005 09:30 ET

Holmes Herbs Creates Holmes Biopharma Division

SCOTTSDALE, ARIZONA--(CCNMatthews - Aug. 24, 2005) - Holmes Herbs, Inc., (OTCBB:HMHB), announced today that it has created a division called Holmes Biopharma, for the purpose of entering into the clinical drug research and drug development business.

The company has launched a new website for investors and clients at www.holmesherbs.com and www.holmesbiopharma.com.

"Our strategy is to create one new drug research facility and acquire another existing facility in the coming months" stated John Metcalfe, President and CEO.

On behalf of the Board of Directors

John F. Metcalfe, President and CEO

Certain statements in this press release constitute "forward looking statements" within the meaning of the United States Securities Legislation. The Company's actual results could differ from those in the forward-looking statements. Do not construe this information as investment advice. This is not a solicitation to buy or sell securities. This does not purport to be a complete analysis of the Company. Investing in securities is speculative and carries a high degree of risk. Past performance does not guarantee future results. Readers should consult their own independent advisers with any investment, including any contemplated investment. All information contained in this press release should be independently investigated. This press release contains forward-looking statements. These remarks involve risks and uncertainties. Risks are not limited to quarterly fluctuations in results or the companies' management of growth and competition. Other risks are detailed in the Company's SEC filings. Actual results may differ materially from such information set forth herein.

Contact Information

  • Holmes Herbs, Inc.
    John F. Metcalfe
    President and CEO
    (206) 245-4779